Latest filing published 06 Nov 2025 for 광동헬스바이오.
광동제약: trading record in brief
광동제약 discloses dealings in 광동헬스바이오 to DART (FSS). In total, 2 filings cover trades dated from 5 November 2025 to 6 November 2025.
Purchases make up the whole of the open-market record (2 purchases). The totals do not cover 2 filings with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 6 November 2025 came the latest disclosure, an open-market purchase in 광동헬스바이오. These figures are compiled from regulatory filings published by DART (FSS). They describe what insiders did and are not a recommendation.
Companies and markets linked to 광동제약
Open company profiles for insider transactions, fundamentals and analyst consensus when available.